z-logo
Premium
PDTC, metal chelating compound, induces G1 phase cell cycle arrest in vascular smooth muscle cells through inducing p21 Cip1 expression: Involvement of p38 mitogen activated protein kinase
Author(s) -
Moon SungKwon,
Jung SunYoung,
Choi YungHyun,
Lee YoungChoon,
Patterson Cam,
Kim CheorlHo
Publication year - 2004
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.10728
Subject(s) - pyrrolidine dithiocarbamate , vascular smooth muscle , microbiology and biotechnology , cyclin d1 , cyclin dependent kinase , p38 mitogen activated protein kinases , cell cycle , kinase , signal transduction , chemistry , cyclin e , cyclin dependent kinase 2 , mapk/erk pathway , protein kinase a , biology , nf κb , cell , biochemistry , endocrinology , smooth muscle
Abstract Pyrrolidine dithiocarbamate (PDTC), a metal chelating compound, is known to induce cell death in vascular smooth muscle cells (VSMC). However, the molecular mechanism for PDTC‐induced VSMC death is not well understood. Addition of PDTC reduced cell growth and DNA synthesis on VSMC in low density conditions. However, in serum depleted medium, PDTC did not affect the cell viability, suggesting that certain factors in serum may mediate the cytotoxic effect of PDTC. Several metal chelators prevented the cell death induced by PDTC. In a serum‐deprived condition, addition of exogenous metals, copper, iron, and zinc, restored the cytotoxic effect of PDTC. These data indicate that metals such as copper, iron, and zinc in serum may mediate the cytotoxic effect of PDTC. At low VSMC density in 10% FBS, treatment of PDTC, which induced a cell‐cycle block in G1‐phase, induced down‐regulation of cyclins and CDKs and up‐regulation of the CDK inhibitor p21 expression, whereas up‐regulation of p27 or p53 by PDTC was not observed. Finally, we determined PDTC‐mediated signaling pathway involved in VSMC death. Among relevant pathways, PDTC induced marked activation of p38MAPK and JNK. Expression of dominant negative p38MAPK and SB203580, a p38MAPK specific inhibitor, blocked PDTC‐dependent p38MAPK, growth inhibition, and p21 expression. These data demonstrate that the p38MAPK pathway participates in p21 induction, which consequently leads to decrease of cyclin D1/cdk4 and cyclin E/cdk2 complexes and PDTC‐dependent VSMC growth inhibition. In conclusion, an understanding of the molecular mechanisms of PDTC in VSMC provides a theoretical basis for clinical approaches using antioxidant therapies in atherosclerosis. J. Cell. Physiol. 198: 310–323, 2004© 2003 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here